Skip to main content

Table 1 Molecular classification of breast carcinoma [13]

From: The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes

Feature

Luminal A

Luminal B

HER-2+

Basal like

ER/PR

Positive

Positive

Mostly negative

Negative

HER-2

Negative

May be amplified

Amplified

Negative

Other markers’ positivity

CK 8/18

CK 8/18

Androgen receptor

CK 5/6, EGFR

Proliferation rate (ki67 index)

Low

Intermediate

High

Very high

Recommended therapy

Hormonal

Hormonal and chemotherapy

Herceptin and chemotherapy

Chemotherapy

Prognosis

Favorable

Unfavorable

Poor

Worst